10:45am ET
Health and Healthcare
Ebola Stock Fallout Severe on Monday
Some of the Ebola high-flying stocks saw their share prices crater on Monday as Ebola fears are subsiding for several reasons.
Companies
Sarepta Therapeutics Inc
$20.86
▼ $0.73 (−3.38%) today
Markets closed · 6:44am ET
SRPT Coverage
Page 91:40pm ET
Health and Healthcare
Ebola Stocks Move in Different Directions
Recently we have seen a surge in Ebola-related stocks across the board, but Friday trading brought a mixed view for this group.
Chris Lange 2:05pm ET
Health and Healthcare
Ebola Stocks on the Move
Investors fan the flames of Ebola fears in the market, enabling these biotech companies to profit from these fears.
Chris Lange 12:20pm ET
Health and Healthcare
Ebola Drug Stocks React Wildly to Dallas Patient Death
The sad news that Ebola patient Thomas Eric Duncan has died in a Dallas hospital now raises fears that Ebola drugs might not be a cure-all for patients.
2:05pm ET
Health and Healthcare
Reality Sets in for Ebola Drug Hopefuls
Tekmira Pharmaceuticals downgrade also drags down Sarepta Therapeutics and BioCryst Pharmaceuticals.
9:55am ET
Health and Healthcare
Major Fallout Stocks After Confirmed Ebola Case in United States
With the CDC not releasing enough data on the patient, there could be an opportunity for traders on both sides of the Ebola story.
5:16pm ET
Health and Healthcare
Reaction to Confirmed Ebola Case in U.S. — UPDATED
News has hit of the first confirmed Ebola case in the United States. Companies involved in potential drugs for Ebola have seen their shares pop.
11:20am ET
Health and Healthcare
Analyst Now Sees 75% Upside in Sarepta
Credit Suisse's $36 price target on Sarepta Therapeutics effectively calls for close to 75% upside.
Jon C. Ogg 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Auxilium, Ericsson, GoldCorp, McDonald’s, Micron, Sarepta and More
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Wednesday, September 24, 2014.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Expedia, Hyatt, Ocwen, Strayer, SunPower, 3D Systems and More
These are the top analyst upgrades, downgrades and initiations from Wall Street analysts for Friday. They include Expedia, Hyatt Hotels, Ocwen Financial, Strayer Education, SunPower and 3D Systems.
8:35am ET
Investing
Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 22, 2014. They include Allergan, Amazon.com, Chipotle Mexican Grill, Netflix and Sarepta Therapeutics.
10:50am ET
Health and Healthcare
Companies Betting on the Next 10 Blockbuster Drugs
24/7 Wall St. wanted to evaluate the prospects for several would-be blockbuster drugs. Some of these have approvals already in hand, while others have pending FDA approval verdicts.
10:10am ET
Health and Healthcare
Odds of Sarepta Drug Approval Rise Sharply
Shares of Sarepta Therapeutics went through the roof Monday morning following an announcement that it plans to have a New Drug Application filed with the FDA by the end of 2014 for…
Paul Ausick 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, January 27, 2014. They include Cisco Systems, Lululemon Athletica, Nokia, Peabody Energy and Xerox.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: BlackBerry, Five Below, Micron, Tiffany and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms Monday, December 23, 2013.